UPDATE
: Monday, September 7, 2020
Home
Login
Mobile Version
All
Hospital
Pharma
Bio
Korea‘s Bio Industry
Device/ICT
Policy
People
Life science
Special
Innovation for Survival
Korea’s medical culture series
Korea’s New Candidate Drug Watch List
Special Series in Celebration of KBR's 1st Anniversary
Interview with foreign envoys
Special Series in Celebration of KBR’s 2nd Anniversary
Interview with global pharma
Special Series in Celebration of KBR’s 3rd Anniversary
Special Series in Celebration of KBR’s 4th Anniversary
ASCO 2020 Highlights
Opinion
Reporter’s Notebook
Search
트위터
페이스북
RSS
상단여백
제목보기
제목보기
제목+내용
Sanofi’s acute lymphoblastic leukemia treatment continues to receive reimbursement
Sanofi Genzyme Korea said Monday that Evoltra (Ingredient: Clofarabine), a ...
by Lee Han-soo
|
2018-12-03 14:26
라인
ABL Bio signs licensing-out agreement with TRIGR Therapeutics
ABL Bio said Friday that it has licensed out ABL001, a bispecific antibody ...
by Lee Han-soo
|
2018-12-03 14:26
라인
Prescriptions of anticancer drugs spiked this year
Prescriptions of anticancer medicines jumped during the first 10 months thi...
by Nam Doo-hyun
|
2018-11-30 13:01
라인
Bukwang completes phase-2b test on new diabetes drug
Bukwang Pharmaceutical said Thursday it has completed administering MLR-102...
by Park Gi-taek
|
2018-11-29 15:19
라인
Will Lilly’s breast cancer drug work on prostate cancer?
Lilly said it would test its investigational breast cancer treatment Abemac...
by Lee Hye-seon
|
2018-11-29 15:02
라인
Liver society recommends Gilead’s Vemlidy as 1st-line drug for hepatitis B
The Korean Association for the Study of the Liver has recommended Gilead’s ...
by Lee Han-soo
|
2018-11-29 14:54
라인
Vietnamese health officials visit CJ Healthcare plant
A group of Vietnamese health officials visited CJ Healthcare’s Osong plant ...
by Lee Han-soo
|
2018-11-29 14:53
라인
Abbvie’s Humira gets expanded insurance coverage
Abbvie Korea said Thursday that the Ministry of Food and Drug Safety has ex...
by Lee Han-soo
|
2018-11-29 11:55
라인
Yuhan develops 3-drug combo for hypertension, dyslipidemia
Yuhan Corp. said it has developed a combination drug mixed Duowell (telmisa...
by Lee Hye-seon
|
2018-11-28 15:36
라인
Gilead’s releases research results for hepatitis B treatment
Gilead Science Korea said it has presented the data on the significance of ...
by Lee Han-soo
|
2018-11-28 15:34
라인
‘Novartis’ COPD inhaler shows superior efficacy compared to tiotropium’
Novartis said Tuesday that it has presented the results of BEYOND, a clinic...
by Lee Han-soo
|
2018-11-28 13:12
라인
Dong-A ST unveils clinical trial results for its diabetes treatment
Dong-A ST has released the results of EVERGREEN, a clinical trial for Sugan...
by Lee Han-soo
|
2018-11-28 13:12
라인
Merck unveils clinical trial results for Cetuximab in Chinese patients
Merck has presented the results of phase 3 clinical trial assessing the eff...
by Lee Han-soo
|
2018-11-27 16:53
라인
AstraZeneca underlines clinical efficacy of its SGLT-2 inhibitor drug
AstraZeneca Korea said Tuesday Forxiga (ingredient: dapagliflozin), its SGL...
by Lee Han-soo
|
2018-11-27 15:19
라인
Gilead releases real-world data for hepatitis C treatment
Gilead Science Korea said Tuesday that it has presented a large-scale real-...
by Lee Han-soo
|
2018-11-27 14:44
라인
Bayer’s liver cancer drug proves efficacy with real-world data
Bayer Korea said it has confirmed the clinical efficacy and tolerability of...
by Nam Doo-hyun
|
2018-11-27 14:27
라인
13 firms win nod for bioequivalence test on generics for Parkinson’s
Domestic pharmaceutical companies have been competing to develop generic co...
by Lee Hye-seon
|
2018-11-27 10:44
라인
Pharmaceuticals still use credit card kiting for illegal cash rebates
With the government’s stricter crackdown on illegal rebates, Korean pharmac...
by Nam Doo-hyun
|
2018-11-26 15:01
라인
Daichi Sankyo, BMS in neck-and-neck competition over blood thinners
The competition among drugmakers over non-vitamin K antagonist oral anticoa...
by So Jae-hyeon
|
2018-11-23 16:18
라인
Oscotec’s acute leukemia treatment wins orphan drug status from FDA
Oscotec said Thursday that its SKI-G-801, an FMS (Feline McDonough Sarcoma)...
by Lee Han-soo
|
2018-11-23 14:55
-
이전
61
62
63
64
65
66
67
68
69
-
176 civic groups furious over government-doctors deal
Amgen Korea wins new indication for acute lymphoblastic leukemia drug
UBcare wins patent for tech to monitor suspected infectious diseases
SCM Lifescience punished for delaying adverse reaction report
176 civic groups furious over government-doctors deal
Amgen Korea wins new indication for acute lymphoblastic leukemia drug
UBcare wins patent for tech to monitor suspected infectious diseases
SCM Lifescience punished for delaying adverse reaction report
여백
Most viewed
1
‘Cyramza helped improve gastric cancer treatment in Korea’
2
‘Reduced-dose prasugrel effective for ACS patients undergoing PCI’
3
Amgen Korea wins new indication for acute lymphoblastic leukemia drug
4
SNUBH develops AI model predicting patients at risk of cerebral aneurysm
5
Novavax releases encouraging phase-1 results on Covid-19 vaccine candidate
6
LG Chem, SK Bioscience end sales partnership with Daewoong
7
UBcare wins patent for tech to monitor suspected infectious diseases
8
176 civic groups furious over government-doctors deal
9
Recovered Covid-19 patients suffer from aftereffects – for long
10
Regulator OKs JW Pharma's rheumarthritis drug for treating giant cell arteries
여백
Opinion
[Column] Correct diagnosis leads to proper treatment
[Column] How ongoing doctors’ strike is different from 20 years ago
A Korean-American Doctor asks: Is Korea truly in 2020?
여백
Back to Top